L’Oréal Mexoryl SX Sunscreen Patent Extended As NDA Review Continues
This article was originally published in The Tan Sheet
Executive Summary
L'Oréal has been granted a one-year interim patent extension to June 16, 2004 for UVA sunscreen ingredient Mexoryl SX, according to a notice published by the U.S. Patent & Trademark Office in the June 20 Federal Register
You may also be interested in...
FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data
FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is eligible for inclusion in the OTC sunscreen drug monograph pending a safety and efficacy evaluation could level the playing field among competing manufacturers in the U.S. and offer innovators more flexibility
FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data
FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is eligible for inclusion in the OTC sunscreen drug monograph pending a safety and efficacy evaluation could level the playing field among competing manufacturers in the U.S. and offer innovators more flexibility
FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data
FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is eligible for inclusion in the OTC sunscreen drug monograph pending a safety and efficacy evaluation could level the playing field among competing manufacturers in the U.S. and offer innovators more flexibility